MAXITROL gtt opht fl 5 ml

7680315670179 CH-31567 S01CA01 11.06.1.
MAXITROL gtt opht fl 5 ml
MAXITROL gtt opht fl 5 ml
1 / 2
google

Details

Product number
3156701
CPT
-
Packaging group
5
Unit
ml
Composition
dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini B sulfas 6000 U.I., natrii chloridum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum, hypromellosum, aqua purificata, benzalkonii chloridum 40 µg, ad suspensionem pro 1 ml.

Articles (1)

Maxitrol, Augentropfen
Augentropfen
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/10/2020
Patient information leaflet
Français
15/10/2020
Patient information leaflet
Italien
15/10/2020

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
4.6 MG Substance WIZUS
(N/A)
6000.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
40.0 UG Substance HBESI

Reimbursement information

Public price
CHF 13.45
Specialties list
Yes
Generic
No
SL addition date: 15/03/1968

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
31567
Drug name
Maxitrol, Augentropfen
Galenic form
AUGT
ATC Code
S01CA01
Authorization status
Z
Dispensation category
A
First authorization
20/12/1965
Authorization expiration date
31/12/9999
IT number
11.06.1.
Domain
Human medicine
Field of application
Infizierte Augenentzündungen

Packaging details

Description (FR)
MAXITROL gtt opht fl 5 ml
Description (DE)
MAXITROL Gtt Opht Fl 5 ml
Market launch
20/12/1965
Narcotic (BTM)
No